Key Takeaways
- In Palm Beach County detox coordination, the discharge plan itself is the deliverable — a named receiving clinician, scheduled appointment, and medication decision matter more than the bed.
- Warm handoffs measurably outperform passive referrals, with transition-clinic data showing roughly 58% versus 38% initial visit attendance and 60% versus 30% six-month retention 4.
- For opioid cases, medication continuity and naloxone dispensing before discharge are non-negotiable, since post-detox patients lose tolerance and face heightened overdose risk without MOUD 21.
- Before routing a patient, compare detox partners on documented medication decisions, 72-hour follow-up scheduling, recurrence-of-use protocols, and verified links to 211/988, mobile crisis, and county-funded agencies 16, 20.
The Discharge Plan Is the Product
When you place a patient into medical detox, the bed itself isn’t what you’re buying. The discharge plan you receive back is the product. Everything upstream — the assessment, the tapering protocol, the co-occurring workup — either compresses into a usable handoff or it doesn’t. If the plan reads like a photocopied resource list, the next 30 days will show it.
You already know this. The frustration is that the field still treats aftercare as paperwork completed at the end of a stay rather than the clinical intervention it actually is. Federal guidance is explicit that withdrawal management should not stand alone as an intervention for opioid use disorder; it has to be paired with ongoing medication treatment and linkage to longitudinal care 1. That framing shifts what a good detox partner owes you.
This piece is written for the people doing the coordinating — hospital discharge planners, EAP counselors, drug court coordinators, sober-living intake staff, and clinical case managers routing patients into and out of Palm Beach County detox. The premise throughout: aftercare planning is a warm-handoff engineering problem, and the local infrastructure to solve it is more concrete than most referral lists suggest.
Warm Handoffs Outperform Referral Lists
What a Named Receiving Team Changes
You already know a printed referral list is not a plan. The question is what a patient actually walks into after discharge, and whether a specific human being on the receiving side is expecting them by name, date, and time.
The clearest evidence for why this matters comes from a primary-care-based multidisciplinary transition clinic evaluated against usual referral after emergency-department buprenorphine initiation. Initial-visit attendance was roughly 58% in the transition clinic versus 38% with usual referral, and six-month treatment retention was 60% versus 30% 4. That is a single-system observational study, not a randomized trial, and the entry point was an ED rather than a detox unit — so treat the numbers as directional evidence for how a named receiving team behaves, not as a promised outcome. The mechanism, though, is the point: when a specific clinic team owns the first appointment, prepares the chart, and expects the patient, more people show up and more people stay.
Federal opioid-treatment guidance uses the same logic when it describes a warm handoff as a direct connection to the needed service rather than a phone number 20. For you, the operational version is small and boring:
- a named clinician,
- a scheduled slot inside 72 hours when possible,
- a shared medication plan, and
- a two-way confirmation before the patient leaves the detox bed.
Everything else is a referral list wearing better clothes.
Passive Referral vs Engineered Handoff: An Operational Comparison
It helps to put the two models side by side on measurable dimensions rather than on adjectives. The table below uses the strongest available evidence from the transition-clinic and ED-buprenorphine literature. Both come from opioid-focused populations in specific care settings, so read the deltas as the shape of the effect, not a Palm Beach guarantee.
| Dimension | Passive referral | Engineered warm handoff | Source |
|---|---|---|---|
| Initial follow-up visit attendance | ~38% | ~58% | 4 |
| Six-month treatment retention | ~30% | ~60% | 4 |
| 30-day OUD treatment engagement (ED buprenorphine cohort) | 22.7% | 49.7% | 3 |
| Receiving-team ownership before discharge | Patient calls to schedule | Named clinician, scheduled slot, confirmed | 20 |
The pattern is consistent across three separate literatures: the more the receiving side is engineered before the patient walks out, the more of them arrive and the longer they stay. If your discharge partner cannot describe the receiving clinician by name and the appointment by time, you are looking at a passive referral, no matter what the paperwork calls it.
Documentation That Actually Travels With the Patient
The handoff fails at the paper layer more often than at the clinical one. A receiving MAT clinic that cannot see the last buprenorphine dose, the taper schedule, the co-occurring diagnoses, or the naloxone dispense will re-do the intake — and re-doing intake is how you lose the first 72 hours.
Build the discharge packet as if the receiving team will read exactly one page. Include:
- the current medication and last dose with timestamp,
- the working co-occurring diagnoses,
- an active problem list,
- the recurrence-of-use response plan (see section 4),
- the naloxone dispense record,
- the patient’s stated goals, and
- the named receiving clinician with appointment date and time.
SAMHSA’s opioid-treatment guidance frames these transition-plan elements — direct handoff, medication continuity, overdose-prevention information — as the actual content of a warm handoff rather than a wrapper around a referral 20. Federal co-occurring guidance adds case management, mutual-help linkage, and long-term follow-up as items to negotiate collaboratively before discharge, not after 18.
Send the packet with signed release of information already in the receiving system, not attached to a fax cover sheet. If the release does not arrive before the patient does, the handoff is not warm — it is just faster paperwork.
Medication Continuity as the Aftercare Backbone
Why Withdrawal Management Alone Fails
Here is the uncomfortable part of the job: a well-run detox stay, absent medication continuity, is not a treatment for opioid use disorder. The 2024 national OUD guideline update is direct about this — withdrawal management should not be used as a standalone intervention, and methadone and buprenorphine are the preferred first-line options 1. If the discharge plan you receive back does not name a medication decision (initiate, continue, or documented informed decline), the aftercare plan is already leaking.
The clearest signal that early medication access changes downstream behavior comes from an emergency-department cohort study: at 30 days, 49.7% of patients who received ED buprenorphine were still engaged in OUD treatment, compared with 22.7% of those who did not — an adjusted risk ratio of 1.97 3. The setting matters. This is an ED-initiation study in a low-threshold pathway, not a detox unit, so read it as strong directional evidence for how early medication access shapes retention rather than a promised outcome for every patient leaving detox.
The operational read is straightforward. If the patient is a candidate for MOUD, the medication should be started, or the first receiving-provider dose should be scheduled, before the bed empties. Handing someone a phone number and a taper printout is not continuity.

Choosing Between Methadone, Buprenorphine Formulations, and Naltrexone
You are not the prescriber, but you shape whether the medication decision survives the transition. Federal guidance recognizes methadone, buprenorphine, and extended-release naltrexone as the three medication options, and it flags that formulation choice depends on withdrawal status, patient preference, pregnancy, other medical conditions, prescriber access, insurance, and the patient’s ability to sustain the regimen 21. Those are all coordination variables, not just clinical ones.
Formulation matters for adherence. A recent network meta-analysis suggested lower illicit-opioid-use risk with extended-release buprenorphine than with transmucosal buprenorphine or methadone, though the finding combines randomized and observational evidence and depends on comparators and dosing 13. Treat that as one input for a discussion, not a default protocol.
What you can do at the coordination layer:
- confirm the receiving provider’s medication scope before discharge (not every clinic prescribes methadone, not every clinic offers XR-buprenorphine),
- verify insurance coverage for the specific formulation, and
- make sure the first post-discharge dose is either administered or scheduled with a named prescriber.
When any of those three pieces is missing, expect a gap — and gaps are where tolerance loss meets availability.
The Post-Detox Overdose Window
This is the part of the conversation no one wants to have quickly, so slow down here. A patient who has completed withdrawal management is, by definition, no longer opioid tolerant. Federal clinical guidance is explicit that patients who are no longer tolerant face heightened overdose risk if they do not receive OUD medication after discharge, and it recommends naloxone dispensing alongside overdose-prevention education as part of the plan 21. That is not a general safety tip. It is the physiology of the first two weeks after the bed.
The gap between what should happen and what usually does is stark. In a JAMA Internal Medicine cohort of Medicare beneficiaries followed for a year after a nonfatal overdose, only 4.1% received any MOUD and only 6.2% filled a naloxone prescription 2. That population is older and Medicare-enrolled, so the exact percentages will not map onto a mixed Palm Beach caseload — but the shape of the gap is the point, and it is the same gap your discharge plan has to close on the front end.


A Recurrence-of-Use Response Plan, Written in Advance
First 24 Hours: What the Patient and Family Do
Recurrence is a clinical event, not a moral one. If the plan does not name what happens in the first 24 hours after a return to use, the default response is silence, shame, and delay — and delay is what turns a slip into a run.
Write the first-day protocol on a single page and hand it to both the patient and one named support person before discharge. It should say, in plain language:
- who to call first (the receiving MAT or behavioral-health clinician, by name and direct number),
- what to do if that line is not answered inside two hours (211/988 or the county mobile crisis team),
- where the naloxone is stored and who is trained to use it, and
- one specific safe location the patient can go to that is not their use environment.
Federal opioid-treatment guidance frames this kind of direct, pre-arranged connection as the substance of a warm handoff rather than a fallback 20, and continuing-care research supports treating recurrence as a trigger for rapid reengagement rather than a reason to close the case 7.
Tell the family, in the same conversation, that a call after use is a success. That reframing is the plan.
72 Hours to 30 Days: Recovery-Management Checkups
The window between 72 hours and 30 days is where most passive plans quietly fail. The patient made the first appointment, maybe the second, and then a missed call becomes a missed week. Recovery-management checkups exist to interrupt that drift on a schedule rather than on a crisis.
The continuing-care literature is fairly direct here: scheduled checkups produce better substance-use outcomes and quicker reentry into treatment than assessment-only follow-up, and they work by shortening the time between a return to use and a return to care 7. SAMHSA’s co-occurring guidance describes the same rhythm through case management, relapse-prevention groups, medication follow-up, and mutual-help linkage as ongoing continuing-care services rather than one-time referrals 18.
Build the 30-day cadence into the discharge packet:
- a 72-hour medication check,
- a 7-day clinical contact,
- a 14-day case-management touch, and
- a 30-day recovery-management review with the receiving team.
Assign each contact to a named person. If the receiving provider cannot commit to that schedule before discharge, note it as an open gap rather than assuming someone will pick it up.
Palm Beach County Infrastructure You Can Route Into
211/988, Mobile Crisis, and Stabilization
The strongest crisis line in the plan is the one the patient will actually dial at 2 a.m. In Palm Beach County, that number has a local operator: 211 Palm Beach and Treasure Coast took on the 988 Suicide and Crisis Lifeline in 2022, and the county’s Crisis Now implementation report frames 988 as the front door to a coordinated receiving and stabilization pathway rather than a standalone hotline 17. Write both numbers into the discharge packet — 211 for behavioral-health navigation and general resource routing, 988 for acute crisis — and name them out loud with the patient before the bed empties.
The next tier is mobile response. The county’s Office of Behavioral Health and Substance Use Disorders lists mobile crisis teams available 24 hours a day, seven days a week, along with crisis-stabilization services intended to reduce acute symptoms and support a safe return to the community 16. SAMHSA’s 2025 crisis-continuum guidelines add the piece most plans forget — follow-up contact after crisis discharge measurably reduces the chance of needing crisis services again 19. Put a name and a call-back window on that follow-up, not just a phone number.
County-Funded Agencies and the 2024 BHSUCOD Plan
You are not routing into a vacuum. Palm Beach County’s 2024 Behavioral Health and Substance Use Disorder plan lays out an integrated, coordinated, person-centered, recovery-oriented system of care and names strategies for connecting residents to the services they actually need 15. Read pragmatically, that is a map of who the county pays to be reachable — and the Office of Behavioral Health and Substance Use Disorders publishes the funded-agencies list that operationalizes it 16.
Two coordination habits pay off here:
- verify current capacity, eligibility, and geographic coverage directly with the receiving agency before you write it into the plan — funded status is not the same as an open slot this week.
- use the same list to build a short bench of two or three MAT-capable providers, one crisis-stabilization option, and one recovery-community contact, so the plan does not collapse when your first-choice receiving clinician is out.
A named backup is still a warm handoff; a resource sheet is not.
Recovery Housing When the Home Environment Is Unsafe
Sometimes the honest answer is that the discharge address is the risk. If the patient’s home is actively unsafe, unstable, or tied to their use, sending them back there and hoping the outpatient schedule holds is a plan on paper only. A 2025 systematic review of recovery housing found that, across five randomized and quasi-experimental studies, recovery housing generally outperformed usual care on abstinence, income, employment, and criminal-justice outcomes, with moderate overall evidence 6. The evidence base is small, and effects were inconsistent in some subpopulations, so treat it as a substantive option to place on the table — not a default for every case.
Frame the conversation with the patient early, not on discharge day. Ask about who is in the home, what substances are present, and whether the environment supports the medication and follow-up schedule you just built. If any answer is a problem, a recovery-housing referral belongs in the packet alongside the MAT appointment.
Integrated Behavioral Health, Peer Support, and Family
Coordinating Co-Occurring Mental Health Care
Most of the patients you route into detox arrive with more than one diagnosis. Anxiety, depression, PTSD, and — less often but more urgently — bipolar or psychotic-spectrum conditions ride alongside the substance use, and the aftercare plan either coordinates both or quietly picks one.
An umbrella review of 28 systematic reviews found that integrated or coordinated treatment for co-occurring substance use and common mental-health disorders was generally better than treating one condition alone and usually better than parallel, uncoordinated services 8. The complementary meta-analysis of 47 randomized trials of cognitive-behavioral interventions found benefits for substance-consumption outcomes over usual care, though effects on psychosocial outcomes were less consistent 9. Read those together: coordination matters more than any single modality, and CBT skills are one useful ingredient rather than the whole plan.
At the coordination layer, that means naming a psychiatric prescriber and a therapist in the packet, confirming the receiving behavioral-health team has the co-occurring workup and current medication list, and scheduling the first mental-health contact inside the same 30-day cadence as the MAT visits — not as a separate track the patient has to assemble alone 18.
Peer Navigators and Mindfulness-Based Skills, Scoped Honestly
Peer recovery coaches earn their place in the plan by doing the coordination work clinicians cannot bill for — showing up at the first MAT visit, calling after a missed appointment, sitting with a family through the first hard week. A 2025 systematic review of 28 studies with 12,601 participants concluded the evidence has coalesced around improved treatment engagement and retention, while findings for substance-use outcomes remain preliminary 23. An earlier review reached a similar shape: positive but tentative 12. Use peers for what the evidence supports — engagement, linkage, retention — and do not oversell them as a stand-alone relapse-prevention intervention.
Mindfulness-based relapse prevention deserves the same honest scoping. A systematic review found support for reductions in cravings and frequency of use and improvements in depressive symptoms, with meaningful heterogeneity across programs 24. Offer it as one structured coping-skills option inside a broader plan, not as the plan.
Family Involvement With Consent
Family involvement is a clinical lever, not a default setting. Get explicit consent before the packet leaves the building, and document who the patient has authorized to receive what — the medication plan, the appointment schedule, the recurrence-of-use protocol, the naloxone location.
A systematic review of 41 studies of family interventions for younger populations found associations with reduced substance use, fewer behavioral problems, and improved family functioning 11. The evidence base skews young, so translate cautiously for older adults, and skip family involvement entirely when the relationships are unsafe. When it fits, one trained support person on the plan — reachable, briefed, and prepared — is worth more than a generic family-education handout.
If You Coordinate Discharges Across Multiple Facilities
A quick audience shift: if your desk handles discharges across a hospital system, a drug court docket, an EAP panel, or a multi-site case-management team, the coordination problem scales differently than it does for a single-facility planner. You are not building one warm handoff. You are building the standard that every handoff has to meet, then noticing which sites drift.
Three habits do most of the work:
- Standardize what a completed discharge packet must contain — named receiving clinician, scheduled appointment inside 72 hours, medication decision documented, naloxone dispensed for opioid cases, recurrence-of-use protocol signed by patient and support person — and treat missing fields as escalations, not typos. SAMHSA’s opioid-treatment guidance frames those elements as the substance of a warm handoff rather than optional attachments 20.
- Track two operational metrics per referral source: initial follow-up attendance and 30-day engagement, since those are where passive referrals reveal themselves 3, 4.
- Keep a live short list of MAT-capable, crisis-stabilization, and recovery-housing partners verified for current capacity — the county’s funded-agencies list is the starting point, not the finish line 16.
When one site’s numbers drift, you have a coordination conversation, not a compliance memo.
Working With a Detox Partner Who Treats the Plan as the Product
The short version of everything above: the detox partners worth keeping on your bench are the ones who treat the discharge plan as the deliverable, not the bed. That means a named receiving clinician confirmed before discharge, a documented medication decision, naloxone in hand for opioid cases, a written recurrence-of-use protocol the patient and one support person have read out loud, and the 211/988 and county mobile-crisis numbers on the same page — grounded in the federal warm-handoff standard rather than a resource sheet 20, 16.
Yes, chasing all of that across three systems is exhausting. Every filled naloxone script and every 72-hour follow-up that actually happens is a real win. If you are placing patients into Palm Beach County detox and want a partner who ships the plan you can defend, Sunrise Detox is one number to keep on that bench.
Frequently Asked Questions
What should a Palm Beach aftercare plan include at minimum for an opioid use disorder patient leaving detox?
At minimum: a documented medication decision (initiate, continue, or informed decline) with the first MOUD contact scheduled inside 72 hours, naloxone dispensed with a trained support person shown how to use it, a named receiving clinician, and a written recurrence-of-use protocol. Federal guidance treats these as the substance of a warm handoff, not add-ons 20, 21.
How is a warm handoff different from a standard referral, and does it actually change outcomes?
A warm handoff means a named receiving clinician, a scheduled slot, and a shared medication plan confirmed before discharge — not a phone number. In a single-system evaluation of an ED-initiated buprenorphine pathway, a multidisciplinary transition clinic saw roughly 58% initial-visit attendance and 60% six-month retention versus 38% and 30% with usual referral 4.
Which Palm Beach County resources should be named in a discharge plan for after-hours crises?
Name 211 Palm Beach and Treasure Coast (which operates 988 locally) for behavioral-health navigation and acute crisis, plus the county’s 24/7 mobile crisis team and crisis-stabilization services listed by the Office of Behavioral Health and Substance Use Disorders 16, 17. Assign a specific follow-up contact after any crisis touch, per SAMHSA’s 2025 crisis-continuum guidance 19.
What should the recurrence-of-use response plan say the patient and family do in the first 24 hours?
On one page: call the named receiving clinician first; if unreached in two hours, call 211 or 988 or the county mobile crisis team; retrieve the naloxone from a stated location with a trained support person; move to one pre-agreed safe location. Continuing-care evidence supports treating recurrence as a trigger for rapid reengagement, not case closure 7.
When is recovery housing the right recommendation instead of returning home?
Recommend it when the discharge address is unsafe, unstable, or actively tied to use — active substances in the home, unsupportive cohabitants, or an environment that undermines the medication and follow-up schedule. A 2025 systematic review of five studies found recovery housing generally outperformed usual care on abstinence, income, employment, and criminal-justice outcomes, with moderate evidence 6.
How should co-occurring mental health care be coordinated in the aftercare plan?
Name a psychiatric prescriber and a therapist in the packet, share the co-occurring workup and medication list with them, and schedule the first mental-health contact inside the same 30-day cadence as the MAT visits. An umbrella review of 28 systematic reviews found integrated or coordinated treatment generally outperforms parallel, uncoordinated services for common co-occurring conditions 8, 18.
References
- Management of opioid use disorder: 2024 update to the 2020 national guideline. https://pubmed.ncbi.nlm.nih.gov/39532476/
- Overdose, Behavioral Health Services, and Medications for Opioid Use Disorder After a Nonfatal Overdose. https://pubmed.ncbi.nlm.nih.gov/38884975/
- Emergency Department Access to Buprenorphine for Opioid Use Disorder. https://pubmed.ncbi.nlm.nih.gov/38285444/?dopt=Abstract
- Evaluation of a Primary Care-Based Multidisciplinary Transition Clinic for Patients Newly Initiated on Buprenorphine in the Emergency Department. https://pubmed.ncbi.nlm.nih.gov/37675904/
- Recovery support services as part of the continuum of care for substance use disorders: a rapid scoping review. https://pubmed.ncbi.nlm.nih.gov/39873444/
- Recovery housing for substance use disorder: a systematic review. https://pubmed.ncbi.nlm.nih.gov/40115346/
- Impact of Continuing Care on Recovery From Substance Use Disorder. https://pmc.ncbi.nlm.nih.gov/articles/PMC7813220/
- Effectiveness of Psychosocial Interventions for Adults With Substance Use Disorder That Have a Co-Occurring Common Mental Health Disorder: An Umbrella Review. https://pubmed.ncbi.nlm.nih.gov/41192364/
- Cognitive-behaviorally-based interventions for co-occurring alcohol and other drug use and mental health disorders: a meta-analysis. https://pubmed.ncbi.nlm.nih.gov/40543363/
- Interventions targeting patients with co-occurring severe mental illness and substance use in general practice settings: a scoping review of the literature. https://pubmed.ncbi.nlm.nih.gov/39097682/
- Family Intervention Models for Young Adults with Substance Use Disorders: A Systematic Review. https://pubmed.ncbi.nlm.nih.gov/39564277/
- A Systematic Review of Peer Recovery Support Services in Addiction Treatment. https://pubmed.ncbi.nlm.nih.gov/31263434/
- Extended-release buprenorphine versus transmucosal buprenorphine and methadone for opioid use disorder: a systematic review and network meta-analysis. https://pubmed.ncbi.nlm.nih.gov/41521864/
- Overdose Data. https://palmbeach.floridahealth.gov/programs-and-services/wellness-programs/od2a/data-about-the-overdose-epidemic/
- ADVANCING A. https://discover.pbc.gov/communityservices/BHSUCOD/Documents/BHSUCOD2024plan_051324_final.pdf
- Office of Behavioral Health and Substance Use Disorders. https://discover.pbc.gov/communityservices/BHSUCOD/Pages/Funded-Agencies.aspx
- Implementation of the Crisis Now Model in Palm Beach County. https://discover.pbc.gov/communityservices/BHSUCOD/Documents/Implementation%20of%20the%20Crisis%20Now%20Model_Final%20Report%20(5).pdf
- Substance Use Disorder Treatment for People With Co-Occurring Disorders TIP 42. https://library.samhsa.gov/sites/default/files/SAMHSA_Digital_Download/PEP20-02-01-004.pdf
- 2025 National Guidelines for a Behavioral Health Coordinated System of Care. https://988crisissystemshelp.samhsa.gov/sites/default/files/2025-04/national-guidelines-crisis-care-pep24-01-037.pdf
- Federal Guidelines for Opioid Treatment Programs. https://library.samhsa.gov/sites/default/files/federal-guidelines-opioid-treatment-pep24-02-011.pdf
- Medications for Opioid Use Disorder. https://nida.nih.gov/sites/default/files/tip-63.pdf
- Medications for Opioid Use Disorder. https://nida.nih.gov/research-topics/medications-opioid-use-disorder
- Peer Recovery Support Services and Recovery Coaching for Substance Use Disorder: A Systematic Review. https://pubmed.ncbi.nlm.nih.gov/41551498/
- Effectiveness of Mindfulness-Based Relapse Prevention in Substance Use Disorders: A Systematic Review. https://pubmed.ncbi.nlm.nih.gov/34677226/




